Table 1.
Baseline characteristics of PTC patients.
| Variable | Original PTC patient (N = 380) |
|---|---|
| Gender (male) | 144 (37.8%) |
| Age (years) | 38.84 ± 11.18 |
| Ethnicity (Han) | 368 (96.8%) |
| Diabetes (yes) | 14 (3.6%) |
| Hypertension (yes) | 25 (6.5%) |
| Hyperthyroidism (yes) | 18 (4.7%) |
| Hashimoto’s thyroiditis (yes) | 82 (21.5%) |
| TSH (uIU/mL) | 1.73 (1.13, 2.48) |
| FT3 (pmol/L) | 5.00 (4.58, 5.50) |
| FT4 (pmol/L) | 11.69 (10.2, 12.8) |
| TgAb (IU/mL) | 0.25 (0.017, 6.28) |
| TPOAb (IU/mL) | 0.9 (0.35, 18.2) |
| Tg (ng/mL) | 18.70 (5.54, 56.48) |
| Bilateral LND | 30 (7.8%) |
TSH, thyroid-stimulating hormone; FT3, free triiodothyronine; FT4, free thyroxine; TgAb, thyroglobulin antibodies; TPOAb, thyroid peroxidase antibodies; Tg, thyroglobulin; LND, lateral neck dissection.